Company Overview - Yuyue Medical's stock closed at 35.92 yuan, up 2.69%, with a rolling PE ratio of 20.33, marking a new low in 31 days, and a total market capitalization of 36.009 billion yuan [1] - The company operates in the medical device sector, focusing on the research, manufacturing, and sales of medical devices, with key product areas including respiratory oxygen, diabetes care, infection control solutions, home electronic testing, in vitro diagnostics, emergency and clinical rehabilitation devices [1] - Yuyue Medical has several major brands, including "Yuyue," "Jiefuro," "Huatuo," "Jinzhong," "An'er iodine," "Primedic," and "Liuliu Vision," with significant brand value and advantages due to product performance and effective brand communication [1] Financial Performance - In Q1 2025, Yuyue Medical reported revenue of 2.436 billion yuan, a year-on-year increase of 9.17%, while net profit was 625 million yuan, reflecting a year-on-year decrease of 5.26%, with a gross profit margin of 50.30% [2] - The company's PE ratio (TTM) stands at 20.33, while the industry average is 54.55, and the industry median is 37.54 [2] Shareholder Information - As of July 10, 2025, Yuyue Medical had 40,000 shareholders, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1]